Your search matched a total of 41 documents. Results 1 - 10.
MeSH term: ... of genital herpes and typical dermatomal herpes zoster, all successfully treated with acyclovir, developed... genital herpes. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. Thirty- one patients with first episodes of genital herpes were randomized in a double... / Synonyms: Genital Herpes; Genital Herpes Simplex
Chemical compound: ... Disease relevance of Civamide Intranasal civamide for the treatment of episodic cluster headaches. Civamide( cis- capsaicin) for treatment of primary or recurrent experimental genital herpes. Intranasal civamide for the acute treatment of migraine headache. Civamide altered inducibility in five of six dogs...
MeSH term: ... associated with vaccination. Chemical compound and disease context of Vaccination Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Our results...
MeSH term: ... with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Blockade...
MeSH term: ... Disease relevance of Natural History Zidovudine and the natural history of the acquired immunodeficiency syndrome. We conclude that oral acyclovir given for four months markedly reduces but does not completely prevent recurrences of genital herpes and does not influence the long- term natural history...
Chemical compound: ... . Ineffectiveness of topical idoxuridine in dimethyl sulfoxide for therapy for genital herpes. Psychiatry related...
Chemical compound: ... report: recurrent acyclovir- resistant genital herpes in an immunocompetent patient. Acyclovir to prevent... of recurrent genital herpes. High impact information on Vipral Acyclovir for recurrent herpes simplex virus... Diseases Collaborative Antiviral Study Group. Seventy- seven patients with first episodes of genital herpes...
MeSH term: ... 3. Biological context of Palliative Care Oral acyclovir, palliative therapy for genital herpes...
Chemical compound: ... Disease relevance of edoxudine Treatment for recurrent genital herpes using edoxudine 3% cream for 5 days was evaluated in 200 patients in a randomized, multicenter, double- blind, placebo- controlled, clinic- initiated trial. High impact information on edoxudine Edoxudine reduced viral shedding...
MeSH term: ... in the therapy of herpes keratoconjunctivitis and in the therapy of genital herpes, with maximal benefit seen in those patients who have primary genital herpes. Thus, in the second of this 2- part review series( Part... and a labial biopsy sample for the diagnosis of xerostomaia were studied in all patients. Open- label crossover...
Links to contributing authors:
Steven Johnsen and Donald R. Forsdyke and Kehinde Ross and Andrew Perry and Jonathan Eisen and A. Shimabukuro-Vornhagen and Giuseppe Rotondo and Gordon Laurie and Berkley Lynch and Kung-Hao Liang and Matthias Gstaiger and Thomas Pfeiffer and Marta Ramirez and Grant MacGregor and Jingyu Li and Fedik Rahimov and M El Gizouli and Marta Ramirez Gaite and Oswaldo Ribeiro-filho and Ralf Weigel and Bjoern Hamberger and Alexander Kanitz and Andreas Zankl and Chunming Ding and Maruf Yunus and Jonathan S. Berg and Michael Cariaso and Zakir Thomas and Monique Timberlake-Brady and LC Dore and Nan Shen and R. Eric Collins and Kuang-Mao Chiang and Brendan McMahon and John Chew and Wen-Ming Yang and Robert Hoffmann and J.B. Stewart and Manuela Cucerea and Ignacio García and William James and Thomas Kelder and Gregory Melahn and YINGDE ZHU and Andres Muro and Gabriel Santpere and Jeff Freilich and Junbin Qian and Steffen Poulsen and Eric Villard and Rafael Sidi and Grant Cramer and Chris Sander and Alexandre Chigaev and Florian Uhle and Carl Fulp and Andrew Brown and Xiaozhu Zhou and Corina Dutu and Hilary Spencer and david germano and Abbas Dehghan and Eung-ju PARK and Chris Sander and Albert Vilella and Miao Tian and Anjali Bheda and Michael Nevels and Jun Liu and D Delano and Chitose Taya and Soomi Cheong and David Kavanagh and Maha Karnoub and Hilmar Lapp and Christian Pallasch and Daniel Mietchen and Biju Balakrishnan and Keith Ashman and Juan Carlos Sobrino and Anshu Bhardwaj and Grzegorz Wickiel and Matthew Day and Anthony Sebastian and Vedran Katavic and Liang Long and Barry Wanner and Sarah Snelling and Fernando Montanes and Omobosede Fashedemi and Gustavo Cervantes and Manoj Kumar and Edward D Great and Paul Paukstelis and Roy Soetikno and Ana I Caño-Delgado and Minsoo Choi and Lei Wang and Brenda Riley and A Michelle Moon and Jon Moulton and Mahmoud Elshahawy and Meagan Gillespie and Banundari Rachmawati and Qian Han and Eric Danner and Xavier Fouillet and Madhusudhan Acharya and Brian Young and Chandra Sekhar Mukhopadhyay and shrawan bhattacharjee and Marieke van der Linden and cj hoban and Sandi Pniauskas and jackie gao and Metin Bilgin and Gillian L. Dalgliesh and Karl Wotton and Iveta Herichova and Yuji Morita and Marta Hernandez and Gregor Krings and Marco Briones and Tim D. Smith and Yiumo Michael Chan and Zhenyu Guo and Barry Barclay and Hong Wang and tarali chowdhury and Tilman Brummer and Nuno Faria and Tamir Ben David and Myles Axton and Yannick Fonseca and Francis Castets and Modesto Redrejo-Rodríguez and Bruce Herron and Toshio Fujita and Elena Puccetti and Zhang Zhang and John Osborne and Illes J Farkas and Fernando Andres and Phyllis Pugh and Jonathan Court and Tim Vickers and Nir Friedman and Holger Dick and Ya-Chen Liang and Jonathan Froehlich and Haitham Sobhy and David Abraham and Stephane Krief and Yaroslav Nikolaev and Qiping Feng and d gupta and R Thapar and Susan Wee and Michael Rehman and SOUMITRA GHOSH and Mohamed Eweida and Cedric Uytingco and Nie hongchuan and David Steenblock and Mark A. Kukucka and Zoli Fekete and Sergei Kozlov and Javier Jara and Osama Naguib and Felix Benninger and jean-marc lo-guidice and VASUDEVA BHAT and Anne O. Summers and Bjoern Titz and Anna Levine and Klas Udekwu and Robert Hoffmann